Motivational and Cognitive-Behavioral Management for Alcohol and Pain Intervention (MCBMAP) for Alcohol Use Disorder
Study Summary
This trial compares a remote Motivational & Cognitive Behavioral Intervention to a Brief Advice & Information Control to help HIV patients manage their alcohol use & chronic pain.
- Alcohol Use Disorder
- Pain
- Chronic Pain
- HIV/AIDS
- Problem Drinking
Treatment Effectiveness
Effectiveness Progress
Study Objectives
23 Primary · 11 Secondary · Reporting Duration: baseline, 3 months, 6 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Brief Advice and Information
1 of 2
Motivational and Cognitive-Behavioral Management for Alcohol and Pain Interventi...
1 of 2
Active Control
Experimental Treatment
385 Total Participants · 2 Treatment Groups
Primary Treatment: Motivational and Cognitive-Behavioral Management for Alcohol and Pain Intervention (MCBMAP) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many individuals have chosen to partake in this scientific experiment?
"Affirmative. The clinical trial is currently seeking participants, as documented on clinicaltrials.gov. Initially posted on March 1st 2023 and last updated February 24th 2023, this medical study requires 385 enrollees from a single site." - Anonymous Online Contributor
Is enrollment for this research venture currently underway?
"Confirmed. Information on clinicaltrials.gov demonstrates that the recruitment process for this trial is active and ongoing, having been initiated on March 1st 2023 with a subsequent edit made February 24th of the same year. 385 participants are needed from one particular medical centre." - Anonymous Online Contributor
What is the ultimate objective of this investigation?
"The primary objective for this research, to be observed over a set timeline, is the amount of alcoholic beverages consumed per week. Secondary markers of success include depressive symptoms (assessed through PHQ-8), substance involvement in the past month (measured with NIDA's modified ASSIST procedure), and physical and mental functioning (utilizing RAND's 12-item Health Survey)." - Anonymous Online Contributor